Building more sustainable products to improve life for future generations
公司规模
1,000+
地区
- Europe
国家
- Denmark
产品
- Benchling
技术栈
- API
- Data Warehouse
实施规模
- Enterprise-wide Deployment
影响指标
- Innovation Output
- Productivity Improvements
技术
- 平台即服务 (PaaS) - 数据管理平台
适用功能
- 产品研发
服务
- 系统集成
关于客户
Novozymes is an industrial biotech company based in Bagsværd, Denmark. The company is focused on harnessing the power of enzymes and microbes to solve some of the world’s most pressing challenges. From increasing fuel sustainability to making crops more resilient, Novozymes is building products that will improve the lives of future generations. With more than 700 products and 30% of sales coming from new solutions each year, the scale and speed of Novozymes’ scientific innovation is truly unprecedented. The company employs over 6,000 people and is committed to accelerating its pace of innovation to bring more life-changing products to market, faster.
挑战
Novozymes, a company focused on harnessing the power of enzymes and microbes to solve global challenges, was facing issues with its data management. The company's strain engineering teams were dealing with an increasing volume of data, from hundreds to thousands of samples, which required a more modern digital infrastructure for better connectivity and scalability. The company had many point solutions and regularly brought on new or custom software to address specific scientist needs. Over time, data about plasmids, strains, and assays were spread across multiple systems. Data scientists spent up to 90% of their time trying to reformat data to glean insights. Routine reports were hard to create and even harder to automate. Additionally, scientists had to hunt through Excel sheets, emails, and databases for past results, taking scientists away from science.
解决方案
Novozymes decided to centralize its R&D teams on Benchling through a pilot program. When fully rolled out, this program will allow 1,400 scientists to accelerate the discovery and development of life-changing products. Benchling's modern API and data warehouse interfaces allow Novozymes to integrate Benchling to its existing data lake. Benchling will serve as Novozymes’ central source of truth, following FAIR principles. Laboratory scientists can input and access data using Benchling’s intuitive ELN, and data scientists can easily run machine learning models. Benchling for Lab Automation connects liquid handlers and custom applications, so the team can run assays on resulting strains in bulk and automatically link results to gain insights. Benchling’s unified platform and robust data model makes it easy to connect every step of the strain engineering process from Design and Build (strain ID, genotype, etc.) back to the original DNA. That way scientists can save time on work, such as tracking genetic modifications and identifying unique combinations of DNA parts that could improve strain performance.
运营影响
Case Study missing?
Start adding your own!
Register with your work email and create a new case study profile for your business.
